Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hNSCs Transplantation in SPMS
NCT03282760Phase 1Completed
- Sponsor
- Casa Sollievo della Sofferenza
- Start
- Sep 2017
- Primary completion
- May 2021
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial in secondary-progressive multiple sclerosis (SPMS), sponsored by Casa Sollievo della Sofferenza. Primary endpoints: Incidence of Treatment Emergent Adverse Events at 1 year and Percentage of Mortality at 1 year. Started Sep 2017; status: completed.
02
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT03282760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282760.